Vietnam discusses potential co-operation with Swiss pharmaceutical group

With regard to the current pandemic situation and COVID-19 containment efforts being implemented by regional countries, the Board of Directors of Roche Group provided updated information on the group’s research achievements which can offer an overall solution for COVID-19 prevention and control.

There are therefore two solutions being applied by the nation and other countries, including Realtime PCR tests (RT-PCR) which helps to diagnose and monitor COVID-19 treatment, along with serological tests for antibodies against SARS-CoV-2 in patients who have been exposed to the virus.

Roche Group states that it is planning to increase the production capacity of monthly tests to tens of millions by June and will continue to increase the overall scale of production as swiftly as possible, thereby striving to bring test kits to countries that accept the EU's CE Marking.

At the meeting Ambassador Lan expressed her great appreciation for Roche Group's contributions to bringing effective medical solutions to the wider community and stated her hope that they would continue to co-operate to improve the quality of diagnosis and treatment of patients in the country. This is alongside continuing to launch many community-based schemes for disadvantaged women and children nationwide.

In Switzerland, the self-testing kit for COVID-19 produced by Roche Group in co-operation with the Republic of Korea is now being distributed free of charge in pharmacies. Indeed, this is one of the most reliable and effective testing solutions.

Ambassador Lan said she hopes that in the near future, Roche Group will continue to work closely alongside the Vietnamese Embassy and other health agencies to promptly provide high-quality tests that can be used by local people. In addition, she hopes for continued support in the search for vaccines, research into special drugs, and actively joining hands with the Vietnamese Government and regional countries in the COVID-19 fight.

Roche Group represents the world's leading pharmaceutical group in two main areas of providing diagnostic test and research equipment, whilst it also manufactures pharmaceuticals in order to treat serious diseases such as cancer, HIV/AIDS, metabolic disorders, and inflammatory diseases.

The Swiss pharmaceutical firm has seven representative offices based in Southeast Asia, with over 1,600 employees.

Roche Group is fully committed to continuing to co-operate alongside other countries to find solutions for diagnosis, treatment, research, and production of drugs to combat COVID-19.

As part of the ongoing fight against the pandemic, Roche Group believes that the next important step is the co-operation and sharing of public and transparent information and data of countries to better identify the origin of the disease whilst supporting the production of vaccines and special drugs.